Status:
RECRUITING
The Treatment of Moderate to Severe Allergic Rhinitis With Electroacupuncture Combined With Microneedle Knife
Lead Sponsor:
Pengfei Qiu
Conditions:
Allergic Rhinitis (Disorder)
Electroacupuncture
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Based on the inclusion and exclusion criteria, patients with allergic rhinitis who meet the requirements are selected as trial subjects, and the efficacy is clarified in a randomized controlled design...
Eligibility Criteria
Inclusion
- Those with clinical and laboratory diagnosis of moderate to severe allergic rhinitis;
- Aged ≥18 years and ≤75 years, with no restriction on gender or ethnicity;
- Not taking drugs such as antihistamines or nasal steroids within 1 month before enrollment;
- Those who voluntarily participated in this study and signed an informed consent form, and who were able to adhere to outpatient treatment for 4 weeks.
Exclusion
- Atrophic rhinitis, hypertrophic rhinitis, vasomotor rhinitis, acute and chronic sinusitis, nasal polyps, severe septal deviation, eosinophilia non-allergic rhinitis;
- Those with other allergic diseases such as asthma, urticaria, and colds that cause nasal congestion, runny nose, and sneezing;
- Those who have serious diseases such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems in combination;
- Pregnant or lactating women, psychiatric patients, patients with malignant tumors.
Key Trial Info
Start Date :
April 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06890260
Start Date
April 11 2025
End Date
December 31 2027
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang Hospital
Hangzhou, Zhejiang, China, 310030